Artificial intelligence is changing the Polish medical and pharmaceutical sector
The latest report from the consulting firm Deloitte points to significant changes in the medical and pharmaceutical industries. As many as seven out of ten leaders of companies in the life sciences sector declare that they have made significant progress in implementing solutions based on artificial intelligence (AI).
Enterprises operating in this area are entering the second half of the year with a new approach to business. A key priority for management boards has now become greater discipline in managing available capital. Companies are focusing on cost optimization and increasing the overall productivity of their operations.
The use of artificial intelligence is intended to help in the faster development of new drugs and the streamlining of technological processes. Thanks to modern digital tools, medical companies want not only to respond faster to patient needs but also to manage complex research processes more effectively.
Experts emphasize that investments in new technologies are becoming a necessity in the face of growing market competition. Introducing innovations allows companies to make better use of resources, which in the long term may also bring benefits to Polish patients awaiting modern therapies.
In summary, the medical sector in Poland and around the world is undergoing a process of digital transformation. The focus on productivity and the implementation of advanced AI algorithms are currently the main trends that will shape the development of this industry in the coming months.